News
-
-
REGULATED PRESS RELEASE
BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Biophytis secures approval from ANVISA for OBA clinical trial in Brazil, advancing BIO101 drug candidate for obesity treatment. Key milestone in multinational clinical development -
-
-
-
-
-
-
-